Pricing Log in Create free account

Anavex Life Sciences Corp. (AVXL) vs Unicycive Therapeutics, Inc. (UNCY)

Anavex Life Sciences Corp. and Unicycive Therapeutics, Inc. are both Biotechnology companies. Anavex Life Sciences Corp. and Unicycive Therapeutics, Inc. are of similar size ($104.8M and $102.0M). Across the 8 metrics below, Anavex Life Sciences Corp. leads on 5 and Unicycive Therapeutics, Inc. on 3.

Valuation

Metric AVXL UNCY Biotechnology median
P/E n/m n/m 11.58
P/S n/m n/m 9.61
P/B 0.87 1.91 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA 1.16 n/m 0.72
EV/Sales n/m n/m 9.43
Earnings yield (14.15%) (42.76%) (32.28%)
Free cash flow yield (29.82%) (27.44%) (22.27%)

Profitability

Metric AVXL UNCY Biotechnology median
Gross margin — 0.00% 68.81%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (12.80%) (101.07%) (50.30%)
Return on assets (11.70%) (69.05%) (45.47%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVXL UNCY Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) (3.85%) 70.18% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVXL UNCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.62 3.81 4.74
Net debt to EBITDA 2.00 1.43 1.01

Dividend

Metric AVXL UNCY Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric AVXL UNCY Biotechnology median
Market cap 104.75m 101.95m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack